2011
DOI: 10.1016/j.ejphar.2011.04.043
|View full text |Cite
|
Sign up to set email alerts
|

Regulation mechanism of ABCA1 expression by statins in hepatocytes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
16
0

Year Published

2012
2012
2019
2019

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 30 publications
(16 citation statements)
references
References 21 publications
0
16
0
Order By: Relevance
“…We then examined the effect of a PPAR-α antagonist (GW6471) 9) on the levels of OLHA-induced PPAR-α downstream gene mRNA levels in Clone 9 cells. As shown in Figs.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…We then examined the effect of a PPAR-α antagonist (GW6471) 9) on the levels of OLHA-induced PPAR-α downstream gene mRNA levels in Clone 9 cells. As shown in Figs.…”
Section: Resultsmentioning
confidence: 99%
“…For the experiments, the Clone 9 cells (10 5 cells/10 cm dish) were cul-tured for 72 h, then the sub-confluent cells were incubated in serum-free medium at 37°C for 24 h before the addition of the test compounds. For treatment with GW6471, a PPAR-α antagonist, 9) 10 µM GW6471 was added with the tested compounds. After 48 h, the treated cells were harvested, counted, and used for total RNA extraction.…”
Section: )mentioning
confidence: 99%
“…Primers for FAT were forward: 5 0 -CTCTGACATTTGCAGGTCCA-3 0 and reverse: 5 0 -CACAGGCTTTCCTTCTTTGC-3 0 , whose amplification product is a 214-bp fragment (designed using Primer 3 Software, http://bioinfo.ut.ee/primer3-0.4.0/primer3). Primers for ABCA1 were forward: 5 0 -CAGGCTGATGT-CAGTCTCCA-3 0 and reverse: 5 0 -GGCTTCAGGATGTCCAT-GTT-3 0 , whose amplification product is a 194-bp fragment (Kobayashi et al 2011). The primers for the ribosomal protein L30, used as an internal control were forward: 5 0 -CCATCTTGGCGTCTGATCTT-3 0 and reverse: 5 0 -GGCG-AGGATAACCAATTTC-3 0 , whose amplification product is a 201-bp fragment, (Primer 3 Software).…”
Section: Expression Of Enzymes and Transporters Involved In Lipid Metmentioning
confidence: 99%
“…34, 35 Accordingly, pharmacological inhibition of ABCA1 degradation increases HDL biogenesis, leading to a therapeutic benefit by reducing cardiovascular diseases. 36, 37 Our present study revealed that tBHQ increases ABCA1 protein levels posttranslationally and enhances cholesterol efflux. However, Lee et al demonstrated that the antioxidant quercetin induced an increase in ABCA1 transcript level, which differs from tBHQ in the regulating mechanism.…”
Section: Increased Abca1 Protein Expression and Cholesterol Effluxmentioning
confidence: 85%